SAQUINAVIR MESYLATE (INVIRASE)

Course overview

Saquinavir (SQV) is a protease inhibitor (PI) that is U.S. FDA-approved to treat HIV-1 infections in patients ≥ 16 years of age as part of combination antiretroviral therapy (cART). This continuing education module is designed to give the reader/learner an increased understanding of SQV. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.